Somatostatin and insulin secretion due to common mechanisms by a new hypoglycemic agent, A-4166, in perfused rat pancreas
- 29 February 1996
- journal article
- Published by Elsevier in Metabolism
- Vol. 45 (2) , 184-189
- https://doi.org/10.1016/s0026-0495(96)90051-7
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Effects of N-[(Trans-4-lsopropylcyclohexyl)- Carbonyl]-D-Phenylalanine (A-4166) on Insulin and Glucagon Secretion in Isolated Perfused Rat PancreasPharmacology, 1994
- Pancreatic and Extrapancreatic Sulfonylurea ReceptorsHormone and Metabolic Research, 1992
- The Beta Cell Function in NIDDM Patients with Secondary Failure:Hormone and Metabolic Research, 1992
- Inhibition of ATP-sensitive K+ channels in pancreatic beta-cells by nonsulfonylurea drug linoglirideDiabetes, 1991
- Modulation by somatostatin of nerve‐mediated activation of glycogenolysis in the perfused rat liverFEBS Letters, 1989
- Hyperglucagonemia and Its SuppressionNew England Journal of Medicine, 1978
- Possible roles of the pancreatic D-cell in the normal and diabetic statesDiabetes, 1977
- INFLUENCE OF SOMATOSTATIN ON CARBOHYDRATE DISPOSAL AND ABSORPTION IN DIABETES MELLITUSThe Lancet, 1976
- Diabetes (III): New Hormones Promise More Effective TherapyScience, 1975
- Studies on the inhibition of insulin release, glycogenolysis and gluconeogenesis by somatostatin in the rat islets of Langerhans and isolated hepatocytesBiochemical and Biophysical Research Communications, 1975